Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,933 | 96 | 78.4% |
| Education | $531.25 | 8 | 21.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $482.74 | 25 | $0 (2024) |
| Janssen Biotech, Inc. | $400.84 | 5 | $0 (2024) |
| PFIZER INC. | $192.03 | 13 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $191.65 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $184.02 | 9 | $0 (2024) |
| LEO Pharma Inc. | $169.01 | 9 | $0 (2023) |
| Genentech USA, Inc. | $165.14 | 5 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $141.25 | 3 | $0 (2024) |
| Galderma Laboratories, L.P. | $115.57 | 8 | $0 (2022) |
| Celgene Corporation | $94.75 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $369.94 | 13 | ABBVIE INC. ($140.99) |
| 2023 | $405.07 | 15 | AbbVie Inc. ($121.79) |
| 2022 | $532.69 | 20 | ABBVIE INC. ($149.30) |
| 2021 | $245.47 | 11 | Janssen Biotech, Inc. ($89.95) |
| 2020 | $140.85 | 5 | Janssen Biotech, Inc. ($69.95) |
| 2019 | $191.15 | 10 | Janssen Scientific Affairs, LLC ($49.61) |
| 2018 | $229.32 | 13 | LEO Pharma Inc. ($43.23) |
| 2017 | $350.23 | 17 | Genentech USA, Inc. ($132.11) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $85.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Immunology | ||||||
| 08/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.37 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $68.99 | General |
| Category: Immunology | ||||||
| 06/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: IMMUNOLOGY | ||||||
| 06/05/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Dermatology | ||||||
| 05/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: IMMUNOLOGY | ||||||
| 02/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $34.76 | General |
| Category: IMMUNOLOGY | ||||||
| 01/29/2024 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: BioOncology | ||||||
| 01/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Dermatology | ||||||
| 11/27/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Dermatology | ||||||
| 11/01/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: IMMUNOLOGY | ||||||
| 10/05/2023 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: BioOncology | ||||||
| 09/25/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Dermatology | ||||||
| 09/13/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: DERMATOLOGY | ||||||
| 07/31/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: IMMUNOLOGY | ||||||
| 06/12/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: IMMUNOLOGY | ||||||
| 04/26/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: IMMUNOLOGY | ||||||
| 04/03/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Immunology | ||||||
| 03/30/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $82.95 | General |
| Category: Immunology | ||||||
| 03/29/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 3,490 | 6,592 | $771,790 | $282,205 |
| 2022 | 29 | 3,553 | 6,879 | $793,419 | $284,596 |
| 2021 | 31 | 3,638 | 7,474 | $833,534 | $305,963 |
| 2020 | 26 | 2,826 | 5,639 | $616,335 | $200,456 |
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 976 | 1,300 | $278,200 | $107,387 | 38.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 682 | 828 | $105,984 | $32,639 | 30.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 277 | 326 | $70,090 | $24,275 | 34.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 104 | 158 | $47,084 | $18,644 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 281 | 305 | $44,530 | $17,299 | 38.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 514 | 2,928 | $32,220 | $14,238 | 44.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 66 | 66 | $21,450 | $7,502 | 35.0% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 75 | 83 | $19,422 | $6,787 | 34.9% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 46 | 50 | $17,650 | $6,314 | 35.8% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 31 | 38 | $15,428 | $5,793 | 37.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 21 | 21 | $12,558 | $4,956 | 39.5% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 42 | 50 | $14,200 | $4,955 | 34.9% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 30 | 35 | $12,950 | $4,609 | 35.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 31 | 36 | $12,492 | $4,442 | 35.6% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 27 | 28 | $9,072 | $3,176 | 35.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 42 | 42 | $8,946 | $2,852 | 31.9% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 14 | 14 | $6,748 | $2,630 | 39.0% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 27 | 28 | $9,268 | $1,934 | 20.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 26 | 27 | $5,211 | $1,790 | 34.4% |
| 17280 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 17 | 17 | $4,675 | $1,739 | 37.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 39 | 40 | $3,520 | $1,666 | 47.3% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 15 | 15 | $4,005 | $1,402 | 35.0% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 15 | $4,110 | $1,386 | 33.7% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 23 | 24 | $4,560 | $1,294 | 28.4% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 13 | 13 | $3,094 | $1,065 | 34.4% |
About Dr. John Barton, M.D
Dr. John Barton, M.D is a Procedural Dermatology healthcare provider based in Enola, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831130087.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Barton, M.D has received a total of $2,465 in payments from pharmaceutical and medical device companies, with $369.94 received in 2024. These payments were reported across 104 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,933).
As a Medicare-enrolled provider, Barton has provided services to 13,507 Medicare beneficiaries, totaling 26,584 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Practice Information
- Specialty Procedural Dermatology
- Location Enola, PA
- Active Since 06/09/2006
- Last Updated 03/08/2023
- Taxonomy Code 207NS0135X
- Entity Type Individual
- NPI Number 1831130087
Products in Payments
- TREMFYA (Drug) $400.84
- RINVOQ (Biological) $239.87
- EUCRISA (Drug) $176.21
- Erivedge (Biological) $165.14
- SKYRIZI (Biological) $146.09
- DUPIXENT (Biological) $130.03
- Winlevi (Drug) $120.27
- COSENTYX (Biological) $114.43
- ADBRY (Biological) $92.19
- HUMIRA (Biological) $80.06
- SOOLANTRA (Drug) $76.96
- COSENTYX (Drug) $69.59
- Tremfya (Drug) $49.61
- ENSTILAR (Drug) $46.82
- LIBTAYO (Biological) $33.69
- STELARA (Biological) $33.07
- ILUMYA (Biological) $30.79
- Cimzia (Drug) $26.67
- TALTZ (Drug) $26.63
- EPIDUO FORTE (Drug) $25.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.